focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: OneSavings Upped To Buy, Aldermore Cut To Hold

Thu, 26th Nov 2015 09:45

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
PANMURE LEAVES SAGE GROUP AT 'HOLD' - TARGET 535 PENCE
----------
RBC CAPITAL CUTS AVIVA TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 460 (490)P
----------
NOMURA RAISES COMPASS GROUP PRICE TARGET TO 1,240 (1,162) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS COMPASS GROUP PRICE TARGET TO 1,250 (1,330) PENCE - 'BUY'
----------
JPMORGAN CUTS BHP BILLITON TO 'UNDERWEIGHT' ('NEUTRAL') - PRICE TARGET 750 (1300) P
----------
SOCGEN CUTS BHP BILLITON PRICE TARGET TO 915 (1050) PENCE - 'HOLD'
----------
UBS RAISES BAE SYSTEMS PRICE TARGET TO 580 (510) PENCE - 'BUY'
----------
TRADERS: HSBC ADDS ROYAL DUTCH SHELL TO 'EUROPE SUPER TEN'
----------
RBC CAPITAL MARKETS UPS BG GROUP TO OUTPERFORM FROM SECTOR PERFORM
----------
S&P CAPITAL IQ CUTS STANDARD CHARTERED PRICE TARGET TO 530 (650) PENCE - 'SELL'
----------
GOLDMAN RAISES UNILEVER PLC PRICE TARGET TO 2760 (2415) PENCE - 'SELL'
----------
GOLDMAN RAISES RECKITT BENCKISER PRICE TARGET TO 6345 (6170) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES DIAGEO PRICE TARGET TO 1685 (1600) PENCE - 'SELL'
----------
GOLDMAN RAISES BAT PRICE TARGET TO 3700 (3210) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES IMPERIAL TOBACCO PRICE TARGET TO 3900 (3700) P - 'CONVICTION BUY'
----------
MORGAN STANLEY CUTS HARGREAVES LANSDOWN TO 'EQUAL-WEIGHT' ('OW')- TARGET 1,345P
----------
MORGAN STANLEY RAISES SCHRODERS TARGET TO 3,175 (2,990) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES ABERDEEN ASSET MANAGEMENT TARGET TO 300 (292) P - 'UW'
----------
MORGAN STANLEY RAISES 3I GROUP PRICE TARGET TO 517 (382) PENCE - 'EQUAL-WEIGHT'
----------
FTSE 250
----------
RBC CAPITAL RAISES RPC GROUP PRICE TARGET TO 780 (700) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES RPC GROUP PRICE TARGET TO 850 (829) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES RPC GROUP PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
LIBERUM CUTS PARAGON GROUP PRICE TARGET TO 482 (512) PENCE - 'BUY'
----------
N+1 Lifts Spectris To Hold From Sell, Cuts Target To 1,770p From 2,070p
----------
Investec Upgrades OneSavings Bank To Buy From Hold, Target At 375p
----------
DEUTSCHE BANK CUTS ALDERMORE TO 'HOLD' ('BUY') - TARGET 267 (330) PENCE
----------
Berenberg Cuts Greencore Group Target To 380p From 390p, Keeps Buy
----------
Liberum Cuts Senior Price Target To 255p From 295p, Keeps Hold
----------
Liberum Downgrades Ultra Electronics Holdings To Hold From Buy; Lifts Price Target To 1,950p From 1,900p
----------
UBS RAISES ULTRA ELECTRONICS PRICE TARGET TO 1,950 (1,850) PENCE - 'NEUTRAL'
----------
UBS CUTS PLAYTECH PRICE TARGET TO 960 (990) PENCE - 'BUY'
----------
UBS RAISES QINETIQ PRICE TARGET TO 225 (205) PENCE - 'SELL'
----------
UBS RAISES COBHAM PRICE TARGET TO 300 (280) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES BRITVIC PRICE TARGET TO 775 (750) PENCE - 'HOLD'
----------
SOCGEN RAISES BRITVIC PRICE TARGET TO 870 (760) PENCE - 'BUY'
----------
GOLDMAN RAISES BRITVIC PRICE TARGET TO 833 (795) PENCE - 'CONVICTION BUY LIST'
----------
BERENBERG RAISES SUPERGROUP PRICE TARGET TO 1,800 (1,390) PENCE - 'BUY'
----------
SOCGEN RAISES DAIRY CREST GROUP PRICE TARGET TO 620 (490) PENCE - 'HOLD'
----------
GOLDMAN RAISES DAIRY CREST GROUP PRICE TARGET TO 550 (380) PENCE - 'SELL'
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 4,000 (3,420) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES PZ CUSSONS PRICE TARGET TO 360 (355) PENCE - 'BUY'
----------
GOLDMAN RAISES TATE & LYLE PRICE TARGET TO 615 (470) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS SPIRE HEALTHCARE PRICE TARGET TO 365 (390) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HENDERSON GROUP TARGET TO 330 (300) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY RAISES ASHMORE GROUP TARGET TO 251 (247) P - 'EQUAL-WEIGHT'
----------
MAIN MARKET AND AIM
----------
EXANE BNP CUTS DAILY MAIL PRICE TARGET TO 720 (850) PENCE - 'NEUTRAL'
----------
NOMURA CUTS DAILY MAIL PRICE TARGET TO 800 (865) PENCE - 'NEUTRAL'
----------
SOCGEN RAISES DAILY MAIL TO 'HOLD' ('SELL') - TARGET 725 PENCE
----------
BARCLAYS CUTS DAILY MAIL PRICE TARGET TO 830 (850) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK CUTS DAILY MAIL PRICE TARGET TO 750 (830) PENCE - 'HOLD'
----------
JPMORGAN CUTS HSS HIRE TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 60 (180) PENCE
----------
BERENBERG CUTS HSS HIRE PRICE TARGET TO 43 (60) PENCE - 'HOLD'

----------

Northland Capital Initiated Evgen Pharma With Buy, Target At 79p
----------
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
7 Aug 2019 11:47

Evgen Pharma Gets European Patent Covering Composition Of SFX-01

(Alliance News) - Evgen Pharma PLC on Wednesday said it has secured further intellectual property rights in Europe for SFX-01.The drug development company, focused on breast cancer and said

Read more
5 Aug 2019 11:45

Evgen Pharma To Collaborate With King's College And British Heart

(Alliance News) - Evgen Pharma PLC said Monday that it backs the new research collaboration between King's College London and the British Heart Foundation.The collaboration is how - - a

Read more
18 Jul 2019 13:00

Evgen Pharma Outlook Confident As Progresses Programmes Development

(Alliance News) - Evgen Pharma PLC on Thursday expressed confidence for the year ahead as it continued to progress on the development of its clinical programmes.Ahead of its annual general

Read more
13 Jun 2019 12:21

Evgen Pharma Annual Loss Fractionally Wider On Small Expense Rise

(Alliance News) - Evgen Pharma PLC on Thursday said its loss marginally widened in its most recent financial year due to slightly higher expenses as drug development continues.Clinical drug

Read more
13 Jun 2019 09:03

Evgen Pharma losses edge wider on higher costs

(Sharecast News) - Evgen Pharma on Thursday reported a slightly widened annual loss due to a cost increase, with its results in line with expectations as its drugs remain in the development stage.

Read more
17 Apr 2019 13:17

Evgen Pharma Raises GBP5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Evgen Pharma PLC said Wednesday it raised GBP5.0 million via issue of shares in an oversubscribed placing.The clinical stage drug development company issued 13.1 at

Read more
25 Mar 2019 10:23

Good Headline Results From Evgen Pharma Breast Cancer Study Of SFX-01

LONDON (Alliance News) - Evgen Pharma PLC on Monday announced positive headline results from its phase two Stem trial of SFX-01 in advanced breast cancer.Shares in the clinical-stage drug -

Read more
18 Mar 2019 11:10

Evgen Pharma Expects STEM Trial Read-Out Next Week

LONDON (Alliance News) - Evgen Pharma PLC on Monday said it expects the final read-out of its STEM trial in metastatic breast cancer to be announced early next week, in line with its guidance of

Read more
5 Mar 2019 11:35

Study Of Evgen Pharma's SFX-01 Multiple Sclerosis Drug Shows Promise

LONDON (Alliance News) - Clinical stage drug developer Evgen Pharma PLC on Tuesday said a study has been published showing that its lead product, SFX-01, reduces residual disability in a model of

Read more
5 Feb 2019 09:18

Evgen Pharma Finishes Patient Recruitment For Stroke Treatment Trial

LONDON (Alliance News) - Evgen Pharma PLC on Tuesday said it has completed patient recruitment in its SAS phase II trial for proposed treatment SFX-01.SFX-01 is a planned treatment for a an

Read more
12 Dec 2018 11:11

Evgen Pharma Interim Loss Widens As It Progresses New Drug Trials

LONDON (Alliance News) - Evgen Pharma PLC on Wednesday said its interim loss widened slightly for its most recent half as it focuses on advancing trials.For the six month to September 30, a

Read more
12 Dec 2018 10:10

Evgen Pharma's loss widens amid excitement over cancer treatment

(Sharecast News) - Evgen Pharma's shares stumbled on Wednesday after its interim loss before tax expanded, though the company was "delighted" by progress in treatment developments.

Read more
23 Oct 2018 12:55

David And Monique Newlands Build 5% Stake In Evgen Pharma (ALLISS)

LONDON (Alliance News) - Evgen Pharma PLC said Tuesday that David and Monique Newlands now own 5.06% stake in the company.The Newlands' holding before the transaction, if any, was not

Read more
18 Oct 2018 10:26

Evgen Pharma Raises GBP750,000 Via Share Placing (ALLISS)

LONDON (Alliance News) - Evgen Pharma PLC said Thursday it raised GBP750,000 via share placing.The company issued 5.6 million shares at 13.5p. Shares in the drug development company were at

Read more
11 Sep 2018 12:51

Tueday broker round-up

(Sharecast News) - JD Wetherspoons: Berenberg upgrades to buy with a target price of 1,450p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.